For in vitro diagnostic use. Others ASTL IVD ASTL CPS_000040 Aspartate Aminotransferase 04657543190 AST/GOT 400T cobas c 111 ASTL 04015630921942 Reagents, kits 4 × 100 tests cobas c 111 true 20764949322 ASTL, 500Tests, cobas c, Integra ASTL 04015630913855 Reagents, kits 2056097322 500 tests COBAS INTEGRA 400 Plus, cobas c 311/501/502 true 04863828001 ASTL Aspartate aminotransferase with/without pyridoxal phosphate activation en 9 FF00000006ED320E FF0000000094360E 04657543190 307 cobas c 111 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use In vitro test for the quantitative determination of aspartate aminotransferase, with or without pyridoxal phosphate activation, in human serum and plasma on cobas c 111 systems. en 20764949500 ASTL Aspartate Aminotransferase acc. to IFCC with and without pyridoxal phosphate activation en 17 FF00000006ED340E FF0000000024C80E 20764949322 308 cobas c 311 2324 cobas c 502 309 cobas c 501 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of aspartate aminotransferase (AST) in human serum and plasma on cobas c and COBAS INTEGRA systems.cobas c systems:For cobas c systems the method sheet describes the application for ASTL without pyridoxal phosphate activation.Integra systems:This method sheet describes the application for AST with and without pyridoxal phosphate (PYP) activation on COBAS INTEGRA systems. en 0020764949322COIN ASTL Aspartate Aminotransferase - Pyridoxal phosphate activated en 12 FF0000000591AE0E FF0000000094390E 20764949322 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of the catalytic activity of AST (EC 2.6.1.1; L‑aspartate: 2‑oxoglutarate aminotransferase) in human serum and plasma on COBAS INTEGRA systems. This method sheet describes the application for AST activated by pyridoxal phosphate (test ASTPL, 0‑594). The application for AST without pyridoxal phosphate is described in the method sheet Aspartate Aminotransferase. en 0020764949322COIN ASTL Aspartate Aminotransferase en 11 FF0000000591BB0E FF0000000094380E 20764949322 302 COBAS INTEGRA 400 plus Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useIn vitro test for the quantitative determination of the catalytic activity of AST (EC 2.6.1.1; L‑aspartate: 2‑oxoglutarate aminotransferase) in human serum and plasma on COBAS INTEGRA systems. This method sheet describes the application for AST without pyridoxal phosphate activation (test ASTL, 0‑494). The application for AST activated with pyridoxal phosphate is described in the method sheet Aspartate Aminotransferase - Pyridoxal phosphate activated. en